Media

In a new white paper issued today, BIO updates the results of a study of the greenhouse gas emissions resulting from EPA's proposal to reduce biofuel use...
BIO is pleased to announce the creation of the BIO Rosalind Franklin Award for Leadership in Industrial Biotechnology to be presented to an outstanding...

Press Releases

Feb 22 2001
WASHINGTON, DC (February 22, 2001) --Michael J. Werner, director of federal government relations and bioethics counsel for the Biotechnology Industry...
Feb 16 2001
Washington, D.C. – A record 32 biotechnology drugs, vaccines and new indications for existing medicines were approved by the U.S. Food and Drug Administration...
Feb 15 2001
WASHINGTON, D.C. (February 15, 2001) -- Carl B. Feldbaum,president of the Biotechnology Industry Organization (BIO), issued the following statement today on...
Feb 14 2001
WASHINGTON, D.C. (February 14, 2001) – U.S. Sen. Tim Hutchinson (R-Arkansas) and Newt Gingrich, former Speaker of the U.S. House of Representatives, will be...
Feb 12 2001
WASHINGTON, D.C. (February 12, 2001) - Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), issued the following statement on...
Feb 1 2001
WASHINGTON, D.C. (February 1, 2001) – Following recent announcements by certain groups of plans to clone human beings, the Biotechnology Industry Organization...
Feb 1 2001
The Honorable George W. BushPresident of the United StatesThe White House1600 Pennsylvania Avenue, NWWashington, DC 20500 Dear Mr. President: Recently certain...
Jan 30 2001
WASHINGTON, DC (January 30, 2001) –Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), issued the following statement on President...
Jan 25 2001
WASHINGTON, D.C. (January 25, 2001) – The BiotechnologyIndustry Organization’s (BIO) CEO & Investor Conference next month in New York will showcase the...


Biotechnology News

October 30, 2014

NEW YORK--(BUSINESS WIRE)--Medidata (NASDAQ: MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that it...

October 30, 2014

NEW YORK--(BUSINESS WIRE)--Retrophin, Inc. (NASDAQ:RTRX) today announced that it will report its third quarter financial results on Thursday, November 13, 2014 after the...

October 30, 2014

PALO ALTO, Calif.--(BUSINESS WIRE)--Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) will release its financial results for the third quarter ended September 30, 2014, on...

October 30, 2014

BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq: SGEN) today reported financial results for the third quarter and nine months ended September 30, 2014. The...

October 30, 2014

CARLSBAD, Calif.--(BUSINESS WIRE)--GenMark Diagnostics, Inc. (Nasdaq:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today reported...